Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,877 | -1,350 | -643 | -212 | -7,392 |
| Depreciation Amortization | 20 | 19 | 18 | 9 | 18 |
| Accounts payable and accrued liabilities | 154 | 160 | 36 | 58 | N/A |
| Other Working Capital | -426 | -241 | -340 | 76 | 84 |
| Other Operating Activity | 576 | 335 | 229 | -14 | 6,574 |
| Operating Cash Flow | $-3,554 | $-1,078 | $-700 | $-83 | $-716 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -8 | -8 | N/A | 0 |
| Investing Cash Flow | $-20 | $-8 | $-8 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,295 | 1,507 | 1,407 | N/A | N/A |
| Other Financing Activity | -35 | -77 | -73 | -48 | 1,161 |
| Financing Cash Flow | $10,260 | $1,431 | $1,334 | $-48 | $1,161 |
| Beginning Cash Position | 555 | 555 | 555 | 555 | 111 |
| End Cash Position | 7,241 | 900 | 1,181 | 424 | 555 |
| Net Cash Flow | $6,686 | $344 | $626 | $-131 | $445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,554 | -1,078 | -700 | -83 | -716 |
| Capital Expenditure | -20 | -8 | -8 | N/A | N/A |
| Free Cash Flow | -3,574 | -1,086 | -708 | -83 | -716 |